AFRM vs TRDA · P/E 590, rev $3.22B vs P/E 12, rev $210.8M
Affirm Holdings Inc (AFRM) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the AFRM and TRDA stock pages for the full models.
Not investment advice.